PDIA3P1 is upregulated in TMZ-resistant GBM cell lines; targeting p38α with NEF reduces PDIA3P1-mediated resistance, along with improved antitumor effects when combined with TMZ [66]. The gene discussed is PDIA3P1; the disease is glioblastoma.